# Vesair Continued Access Trial

> **NCT03082118** · NA · COMPLETED · sponsor: **Solace Therapeutics, Inc.** · enrollment: 7 (actual)

## Conditions studied

- Stress Urinary Incontinence

## Interventions

- **DEVICE:** Vesair Bladder Control System

## Key facts

- **NCT ID:** NCT03082118
- **Lead sponsor:** Solace Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-09
- **Primary completion:** 2019-01-15
- **Final completion:** 2019-01-15
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2019-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03082118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03082118, "Vesair Continued Access Trial". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03082118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*